Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,253 total articles
Ondas (ONDS) just reported a breakout quarter and raised full-year guidance, yet the stock has pulled back to a practical entry after a violent run. Between government drone programs, strategic deals and stretched short interest, the setup favors a measured long trade over a 180-trading-day horizon. Valuation is rich today, so risk management is es…
ServiceNow is uniquely positioned to capture the AI-driven automation wave. The stock trades at $120.59 with a $124.3B market cap, premium multiples, and meaningful free cash flow. This trade buys a pullback to $121 with a $165 target over 180 trading days, tight stop at $100. The thesis: AI agents amplify demand for workflow orchestration and inte…
Kraken is uniquely positioned to capture the next wave of institutional crypto adoption. With expanding custody and staking revenues, improving margins and a path to a liquidity event, this trade targets a material rerating. Entry, stop and target detailed below with catalysts and balanced risks.
Frontline's combination of a resilient tanker fleet, recent profitability, a sizable market cap ($7.76B) and an attractive payout creates a favorable tactical buy. Entry at $35.00, stop $31.00, target $40.00 - trade the mid-term freight cycle (45 trading days) while macro and geopolitics keep tanker economics firm.
Micron ($MU) sits on top of the AI memory stack: sold-out high-bandwidth memory (HBM) through 2026 and multi-year contracts are supporting a near-record price and margin optimism. That said, the stock's valuation is rich (market cap ~ $1.21T, P/E ~50, P/S ~20.6) and near-term technicals look stretched. The trade: take a controlled long at $1,074.01…
Danone's shares have pulled back toward the May low after a run-up in 2025. Q1 showed resilient like-for-like sales growth of 2.7% and management reiterated 2026 guidance, while strategic moves (Huel acquisition, Argentina JV) and a successful €1.6bn bond issue improve execution visibility. Technicals are neutral-to-constructive and the stock yield…
Cummins (CMI) is benefiting from two durable, structural demand streams: strong, higher-margin backup power for AI data centers and an emerging recovery in heavy-truck demand. The Power Systems segment is growing at double-digit rates with record margins, and the company’s balance sheet and free cash flow generation leave room for reinvestment and …
Alphabet's stock has pulled back from its May highs but fundamentals remain intact: $4.35T market cap, $64.4B trailing free cash flow, high ROE and a dominant search franchise. An $80B capital raise anchored by a $10B Berkshire commitment is a positive signal for AI infrastructure financing. This trade idea sets a clear entry, stop and target for a…
DHT's cash-generative shipping operations, recent asset sales and newbuild deliveries materially improve liquidity and support a near-9% reported yield. We upgrade to a tactical Buy for a mid-term trade (45 trading days) with a clear entry, stop and target, balancing income capture and upside from improving earnings visibility.
Caledonia's Bilboes feasibility study materially increases theoretical upside by adding 1.749 Moz of reserves and a potential 200,000 oz/year first-full-year profile, but the project is years from production and sits alongside legacy Zimbabwe exposures. With the stock trading near $21 and a market cap of $405.7M, a disciplined swing trade can captu…
Alphabet’s enormous balance sheet, accelerating Google Cloud, and a recent $80B capital raise (with Berkshire buying $10B at a discount) set up a high-probability trade. Valuation looks full but not frothy given $64.4B in free cash flow and 33% ROE. Technicals show a pullback; use a disciplined entry at $360, stop at $340 and a primary target of $4…
Celcuity (CELC) pulled back after a recent data-driven selloff, but the fundamentals and upcoming FDA decision (PDUFA 07/17/2026) argue for buying the dip. The company has strengthened its cash position, published positive Phase 3 cohort results, and benefits from heavy institutional ownership. This trade idea lays out an actionable mid-term long t…
Century Aluminum (CENX) has been a standout beneficiary of higher aluminum prices and domestic supply-sourcing programs. Technicals show steady momentum above short- and medium-term moving averages, fundamentals are improving, and the company holds strategic partnerships that could lift earnings. This trade idea lays out a mid-term (45 trading days…
Jensen Huang's COMPUTEX nod and Nvidia's $2B stake have vaulted Marvell into the spotlight. Fundamentals show real AI-data-center exposure, but valuation and stretched technicals demand a disciplined entry and tight risk controls. This trade plan targets further upside over a 45-trading-day swing while limiting downside if the rally cools.
EZJ, a 2x leveraged ETF tracking the MSCI Japan Index, is trading near $66.05 with improving technicals, recent outperformance by Japan equities, and a compact market cap that makes intraday liquidity nuanced. This trade idea lays out a mid-term (45 trading days) long with tight risk controls to capture continued upside while acknowledging leverage…
Covista (CVSA) is not a headline-free rebound, but the stock now sits at a more attractive entry after a pullback and a period of consolidation. With a market cap near $4.15B, free cash flow of $336M and a P/E in the high-teens, the balance of fundamentals vs. technical risk favors a tactical long position for a position horizon (46-180 trading day…
Palantir's strong Q1 growth, exceptional margins, and strategic partnerships have turned its rich multiples from a showstopper into a calculated risk. This trade idea lays out an entry at $148.00, a stop at $119.00 and a target of $190.00 over a 180-day horizon, with catalysts and a balanced view of risks.
Legend Biotech (LEGN) is trading near $36.51 after a fresh rally tied to positive data and analyst interest. The company has commercial momentum with CARVYKTI sales and improving manufacturing scale; the trade is a momentum swing long into the 52-week high at $45.30 with a defined stop to manage biotech volatility.
Novo Nordisk is trading at roughly $43 with a market cap near $193B and a P/E of ~10. The market has punished the stock for near-term pricing and competition in GLP-1 drugs, but fundamentals - recurring revenue from diabetes and obesity care, an expanding oral Wegovy adoption, and a healthy dividend - argue for a re-rating if growth normalizes in 2…
AT&T trades at single-digit earnings multiples with a healthy free cash flow profile, a roughly 4.5% dividend yield, and a $19 billion California fiber commitment that demonstrates capital allocation toward durable growth assets. We present a long trade with disciplined risk controls that targets a meaningful multiple expansion while capturing inco…
Star Bulk (SBLK) pays a $0.50 distribution with ex-date 06/12/2026 and sits at $27.39. On a baseline interpretation that $0.50 is a quarterly payment, annualized cash could be $2.00 per share (roughly 7.3% yield). More interestingly, one scenario — monetizing asset value roughly equivalent to the $470.5M 16-vessel package discussed in recent transa…
Roku has cleared a key scale milestone - more than 100 million streaming households - and is turning that reach into accelerating platform revenue and free cash flow. The business mix is shifting from hardware to higher-margin ads and subscriptions; given improving profitability, robust FCF, and a still-conservative runway for ad monetization, I re…
Hexcel (HXL) sits at the center of a multi-decade shift toward lightweight composites across commercial aerospace, space launch vehicles, and defense platforms. With a $6.6B market cap, positive free cash flow and exposure to markets growing at ~8%+ CAGRs, HXL offers a way to play structural demand. This trade idea recommends going long with an ent…
Rocket Lab (RKLB) has posted rapid top-line growth and a backlog north of $2 billion while preparing the Neutron reusable rocket for a maiden flight by the end of 2026. At $123.31 the stock already prices a great deal of future optionality — this trade buys a defined-risk position ahead of key catalysts while acknowledging high valuation and execut…
Apple is benefitting from AI integration across its ecosystem without the heavy data-center capex that burdens other AI leaders. With recurring services growth, $129B in trailing free cash flow, and a $4.63T market cap trading at ~38x earnings, I upgrade AAPL to Buy and propose a mid-term swing trade to capture post-WWDC re-rating and continued iPh…
